L. Bjermer

Publications423
h-index56
Citations11,463
Highly Influential Citations364
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • C. Bachert
  • 1,084 Publications, 40,344 Citations
  • J. Bousquet
  • 841 Publications, 57,348 Citations
  • P. Hellings
  • 332 Publications, 14,259 Citations
  • D. Price
  • 440 Publications, 10,836 Citations
  • Publications
  • Influence
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome.
It is increasingly clear that asthma is a complex disease made up of number of disease variants with different underlying pathophysiologies. Limited knowledge of the mechanisms of these disease… Expand
  • 878
  • 26
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)
Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with the mono-components was evaluated in patients with moderate to very severe chronic obstructive pulmonary… Expand
  • 283
  • 23
  • PDF
How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?
Evidence-based medicine is a corner stone in treatment decision making and large randomised, clinical trials are usually designed in order to provide highly significant results. This study was… Expand
  • 283
  • 12
Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.
Asthma-like symptoms, methacholine hyperresponsiveness, and use of asthma medication are prevalent in elite cross-country skiers. We quantitated mucosal inflammatory cell infiltration and tenascin… Expand
  • 320
  • 11
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.
BACKGROUND This phase 3 study further characterizes the efficacy and safety of reslizumab (a humanized anti-IL-5 monoclonal antibody) in patients aged 12 to 75 years with asthma inadequately… Expand
  • 254
  • 10
Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study.
The purpose of this study was to develop new prediction equations for flow/volume spirometry parameters in asymptomatic, never-smoking adults in Norway, and to assess any differences of these… Expand
  • 140
  • 10
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
BACKGROUND Tiotropium + olodaterol improves lung function and symptoms compared to monotherapies in chronic obstructive pulmonary disease (COPD). The OTEMTO 1 and 2 studies investigated the effects… Expand
  • 124
  • 9
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.
RATIONALE IL-9 is a pleiotropic cytokine that has multiple effects on structural as well as numerous hematopoietic cells, which are central to the pathogenesis of asthma. OBJECTIVES The… Expand
  • 175
  • 8
Achieving asthma control in practice: understanding the reasons for poor control.
Achieving asthma control remains an elusive goal for the majority of patients worldwide. Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this requires… Expand
  • 198
  • 8
Bronchoscopy and bronchoalveolar lavage findings in cross-country skiers with and without "ski asthma".
Bronchial hyperresponsiveness to methacholine with asthma-like symptoms ("ski asthma") is frequent in elite cross-country skiers. To further the understanding of "ski asthma", 10 nonasthmatic,… Expand
  • 138
  • 7